Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by OysterBuctoucheon Dec 19, 2019 3:13pm
150 Views
Post# 30473858

Bioasis December 19 2019

Bioasis December 19 2019Lots of negativity and unfair comments on the board past few days. Failed plans /failed people etc..While every shareholder would be feeling the unease of current SP -not sure how anybody benefits from the negativity. Be negative about the share price /the long time waiting for the business model to develop and the lack of cash. Those are all real but for every single person who invested in this company they knew or should have known the risks involved. Compare Denali burning through 55 million a quarter to Bioasis burn rate ? Well in fact Bioasis does not have a burn rate -it only smolders. Despite all of this the science continues to progress-slowly. Which is an inevitable relationship it has with the lack of cash. Patents set up strategically around the world. Highly skilled people continue to dedicate themselves to this company. All for the science. There is no doubting that there has never been a better time to be associated with Bioasis. Despite the SP.

December 27 will pass and a new tax year will begin.There will be soon be events and developments that will make penny sell offs a thing of the past. 
Bullboard Posts